Andrew Schwab
SlowingNamed in filings at Excelerate Health VenturesOn the current fund
- Board seats filed
- 19
Named in filings at Excelerate Health VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Ride Health | Healthcare services | November 2024 | None on file |
| S2N Health | Data & analytics | May 2024 | None on file |
| Skye Bioscience | Biotech & pharma | August 2023 | None on file |
| Radionetics Oncology | Biotech & pharma | August 2023 | None on file |
| Itiliti Health | Digital health | August 2022 | Altitude Ventures, Resolute Venture Partners |
| Huma.AI | Digital health | January 2022 | Hatteras Venture Partners, ShangBay Capital |
| BEKHealth | Digital health | June 2021 | Hatteras Venture Partners |
| Camp4 Therapeutics | Biotech & pharma | March 2021 | Polaris Partners |
| TMRW Life Sciences | Digital health | December 2019 | None on file |
| RareCyte | Biotech & pharma | December 2019 | Arboretum Ventures |
| Assay Depot | E-commerce & marketplaces | November 2019 | Transformation Capital |
| Nido Biosciences | Biotech & pharma | August 2019 | None on file |
| Escient Pharmaceuticals | Biotech & pharma | March 2018 | None on file |
| GenePeeks | Biotech & pharma | September 2016 | None on file |
| Cleave Biosciences | Biotech & pharma | June 2016 | Orbimed Genesis, U.S Venture Partners |
| Purigen Biosystems | Biotech & pharma | March 2016 | None on file |
| Pear Therapeutics | Digital health | January 2016 | Arboretum Ventures |
| Precision Nanosystems | Biotech & pharma | September 2015 | Westlake Biopartners |
| BIRD ROCK BIO | Biotech & pharma | March 2014 | Versant Venture Capital |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Andrew Schwab on the board, based on 19 filed seats with a verified or cited source.